Analyst Ratings for Alder Biopharm (ALDR)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 4.7 / 10
Percentile Rank: 48%
Rating Score: 4.7 / 10
Percentile Rank: 48%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/17/2019 | UBS | Andrew Ang | Upgrade | Neutral (Sell) |
19.50 (9.00) |
10.06 (18.88) |
87.67% | Details |
| 9/17/2019 | Leerink Partners | Marc Goodman | Downgrade | Market Perform (Outperform) |
20.00 (21.00) |
10.06 (18.88) |
87.67% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
